Treatment of depression in an adolescent with cardiomyopathy and arrhythmia

Patients with cardiomyopathy have a higher incidence of mood and anxiety disorders, resulting in greater probability for hospitalisation and increased risk for arrhythmia and death. We report a case of a 16-year-old boy with Danon disease, Wolff–Parkinson–White syndrome, and hypertrophic cardiomyopa...

Full description

Saved in:
Bibliographic Details
Published in:Cardiology in the young 2015-10, Vol.25 (7), p.1418-1420
Main Authors: Tanidir, Canan, Tanidir, Ibrahim C., Tuzcu, Volkan
Format: Article
Language:English
Subjects:
Adolescent
Antidepressants
Antidepressive Agents, Tricyclic - therapeutic use
Anxiety - drug therapy
Brief Reports
Cardiac arrhythmia
Cardiomyopathy, Hypertrophic - psychology
Depression - drug therapy
Electrocardiography
Fear & phobias
Glycogen Storage Disease Type IIb - psychology
Heart attacks
Humans
Male
Mianserin - analogs & derivatives
Mianserin - therapeutic use
Weight Loss - drug effects
Wolff-Parkinson-White Syndrome - diagnosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with cardiomyopathy have a higher incidence of mood and anxiety disorders, resulting in greater probability for hospitalisation and increased risk for arrhythmia and death. We report a case of a 16-year-old boy with Danon disease, Wolff–Parkinson–White syndrome, and hypertrophic cardiomyopathy, who later developed depression and significant weight loss. The patient was successfully treated for his anxiety and depression with mirtazapine without any adverse cardiac effects.
ISSN:1047-9511
1467-1107
DOI:10.1017/S1047951114002303